Table 1.
Clinicopathological parameters of gastric cancer patients studied in tissue microarray
| N(%) | GCRG213p negative | GCRG213p positive | P value | |
|---|---|---|---|---|
| Gender |
|
|
|
|
| Male |
144(82.28%) |
31 |
113 |
0.111 |
| Female |
31(17.72%) |
11 |
20 |
|
| Age |
|
|
|
|
| <65 year |
104(59.43%) |
31 |
73 |
0.029 |
| ≥65 year |
71(40.57%) |
11 |
60 |
|
| Smoking |
|
|
|
|
| Yes |
45(27.27%) |
7 |
38 |
0.278 |
| No |
120(72.73%) |
30 |
90 |
|
| Drinking |
|
|
|
|
| Yes |
28(16.97%) |
2 |
26 |
0.060 |
| No |
137(83.03%) |
35 |
102 |
|
| Family history of tumor |
|
|
|
|
| Yes |
14(8.43%) |
2 |
12 |
0.639 |
| No |
152(91.57%) |
36 |
116 |
|
| Tumor location |
|
|
|
|
| Cardiac |
48(27.43%) |
8 |
40 |
0.360 |
| Body |
37(21.14%) |
10 |
27 |
|
| Antrum |
90(51.43%) |
24 |
66 |
|
| Tumor size (cm) |
|
|
|
|
| ≤1 |
11(6.29%) |
3 |
8 |
0.506 |
| 1-3 |
42(24.00%) |
13 |
29 |
|
| >3 |
122(69.71%) |
26 |
96 |
|
| Depth of invasion |
|
|
|
|
| T1 |
46(26.28%) |
12 |
34 |
0.635 |
| T2 |
21(12.00%) |
7 |
14 |
|
| T3 |
33(18.86%) |
6 |
27 |
|
| T4 |
75(42.86%) |
17 |
58 |
|
| Lymph node involvement |
|
|
|
|
| Yes |
75(42.86%) |
16 |
59 |
0.592 |
| No |
100(57.14%) |
26 |
74 |
|
| Grade of tumor differentiation |
|
|
|
|
| Well |
10(5.71%) |
0 |
10 |
0.001 |
| Moderate |
40(22.86%) |
4 |
36 |
|
| Poor |
103(58.86%) |
27 |
76 |
|
| Signet ring cell |
22(12.57%) |
11 |
11 |
|
| Tumour stage (TNM) |
|
|
|
|
| 0 |
21(12.00%) |
3 |
18 |
0.217 |
| Ia |
14(8.00%) |
6 |
8 |
|
| Ib |
41(23.43%) |
10 |
31 |
|
| II |
60(34.29%) |
17 |
43 |
|
| IIIa |
39(22.28%) |
6 |
33 |
|
| Lauren’s classification |
|
|
|
|
| Intestinal type |
153(87.43%) |
31 |
122 |
0.015 |
| Diffuse type |
22(12.57%) |
11 |
11 |
|
| Resection margin |
|
|
|
|
| Presence |
6(3.43%) |
0 |
6 |
0.361 |
| Absence |
169(96.57%) |
42 |
127 |
|
| Microvascular invasion |
|
|
|
|
| Presence |
20(11.43%) |
5 |
15 |
0.911 |
| Absence |
155(88.57%) |
37 |
118 |
|
| Status |
|
|
|
|
| alive |
121(71.18%) |
30 |
91 |
0.483 |
| dead |
49(28.82%) |
9 |
40 |
|
| 5 year survival |
|
|
|
|
| <5 yr |
47(43.93%) |
12 |
48 |
0.871 |
| > = 5 yr | 60(50.07%) | 10 | 37 |